Cambridge Innovation Capital

CIC combines a unique relationship with the University of Cambridge with deep financial and industry links to support rapidly growing intellectual property rich companies in the Cambridge Cluster. The company is committed to building leading businesses from brilliant technologies, with the benefit of some of the most influential figures in the sector and a patient capital structure.

Michael Anstey

Partner

Carol Cheung

Principal

Anne Horgan

Partner

Ian Lane

Partner

Sohaib Mir

Investment Associate

LR

Louise Rich

Head Of Investor Relations and Communications

RT

Robert Timothy Sprawson

Partner, CFO and Board Member

Rob Sprawson

Partner and CFO

Robert Tansley

Partner

Chris Tapper

Associate

Andrew Williamson

Managing Partner

74 past transactions

Imagen Ltd

Series A in 2015
Imagen Ltd designs and develops media archive management solutions. The company offers Imagen2, a media asset management and publishing system; ImagenCloud, a cloud based system to manage and publish videos and images; and Orbital, a compliance recording system. Its clientele include Ministry of Defence, The Police, The BBC, ITN, The Imperial War Museum, British Telecom, and British Pathe. Imagen Ltd was formerly known as Cambridge Imaging Systems Limited and changed its name to Imagen Ltd in August 2015. The company was founded in 1991 and is based in Willingham, United Kingdom.

Imagen Ltd

Series A in 2014
Imagen Ltd designs and develops media archive management solutions. The company offers Imagen2, a media asset management and publishing system; ImagenCloud, a cloud based system to manage and publish videos and images; and Orbital, a compliance recording system. Its clientele include Ministry of Defence, The Police, The BBC, ITN, The Imperial War Museum, British Telecom, and British Pathe. Imagen Ltd was formerly known as Cambridge Imaging Systems Limited and changed its name to Imagen Ltd in August 2015. The company was founded in 1991 and is based in Willingham, United Kingdom.

Origami Energy Ltd.

Venture Round in 2014
Origami Energy Ltd., a technology company, develops and commercializes a technology platform for distributed energy applications. It offers technology and solutions to connect, control, and manage a network of existing energy generating/energy using/energy storing assets connected to the electricity grid. The company was incorporated in 2013 and is based in London, United Kingdom.

Origami Energy Ltd.

Series B in 2018
Origami Energy Ltd., a technology company, develops and commercializes a technology platform for distributed energy applications. It offers technology and solutions to connect, control, and manage a network of existing energy generating/energy using/energy storing assets connected to the electricity grid. The company was incorporated in 2013 and is based in London, United Kingdom.

Undo

Series B in 2018
Undo Ltd. develops debugging tools for developers, software architects, product managers, and field application engineers. It offers live recorder that records and replay the execution of software, records the programming errors, debug the recordings, and integrates and automates container platform. The company also provides UndoDB, an interactive reversible debugger for C/C++ on Linux and Android. It serves data management, networking, electronic design automation, and financial industries. Undo Ltd. was incorporated in 2005 and is based in Cambridge, United Kingdom with an additional office location in San Francisco, California.

Inivata

Series A in 2016
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumour DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored and treated.

PROWLER.IO

Corporate Round in 2020
Founded in 2016 with a mission to empower people in business to make better decisions, Secondmind - The Decisions Company - is underpinned by years of award-winning, practical artificial intelligence (AI) and machine learning (ML) research, performed by a team of world-class researchers, data scientists and ML engineers. Secondmind closes the gap between people and AI, and supercharges decision-making with the Secondmind Decision Engine, an intuitive and insightful software platform that helps people in industries from supply chain to automotive predict, plan, influence outcomes, manage risk, and make complex decisions with ease and confidence. Secondmind is backed by leading venture funds including Amadeus Capital, Atlantic Bridge, and Cambridge Innovation Capital, among others.

Exvastat

Seed Round in 2017
Exvastat is an innovative, preclinical-stage pharmaceutical company founded in 2016. The company is developing a treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The new treatment has the potential to significantly reduce the high mortality and incapacitating morbidities caused by ARDS, as well as the costs of caring for these critically ill patients to health service providers.

Audio Analytic Ltd.

Series A in 2017
Audio Analytic is the pioneer of sound recognition and is on a mission to give all machines a sense of hearing beyond speech and music. Its embedded, cloudless AI software gives consumer technology the sense of hearing. By understanding what is happening around these products Audio Analytic provides devices and services with contextual awareness, that empower multiple applications across key values such as safety, security, wellbeing, health, entertainment, and communication. Founded in 2010, Audio Analytic is based in Cambridge, UK.

GeoSpock Ltd.

Venture Round in 2020
GeoSpock Limited develops data indexing platform, which provides analytics, builds insight, and enables predictions across space and time. The company's products include GeoSpock DB Discovery and GeoSpock DB Enterprise that offers cloud-based database service for all location tagged information and enables the user to carry out dynamic data fusion and query complex data for performance analytics. It powers any location based service from real time tracking of entire logistics fleets to local taxi finding application. The company was incorporated in 2013 and is based in Cambridge, United Kingdom with additional offices in Tokyo, Japan; and Singapore.

Carrick Therapeutics

Series A in 2016
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated. The company's therapeutics target molecular pathways that drive the most aggressive and resistant forms of cancer using innovative mechanisms, enabling cancer patients to get their predictive biomarkers detected and get their treatments started from early stage.
Storm Therapeutics Limited discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. Storm Therapeutics Limited was formerly known as Iceni Therapeutics Limited and changed its name to Storm Therapeutics Limited in June 2016. The company was incorporated in 2015 and is based in Cambridge, United Kingdom.
CMR Surgical is to make minimal access surgery available to all. With Versius they have delivered a next-generation tool to fit seamlessly into today’s operating rooms, working in harmony with the surgeon to improve patient outcomes and deliver value for healthcare providers.

Congenica Ltd.

Venture Round in 2014
Congenica Ltd. develops and operates clinical data solutions for genetic diagnosis worldwide. The company offers Sapientia, a clinical genomic analytics platform that provides integration of human DNA sequences with deep clinical phenotyping, enabling clinicians and researchers to provide actionable interpretation of genetic disease for patients. Its platform is also used for clinical diagnosis, prognosis, and research by clinicians and researchers. The company’s platform is also used in personalized medicine applications, such as creating disease registries, identifying patient populations for clinical studies, and discovering novel drug targets and biomarkers. Congenica Ltd. was incorporated in 2012 and is based in Hinxton, United Kingdom.

Inivata

Venture Round in 2014
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumour DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored and treated.

Inivata

Series B in 2019
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumour DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored and treated.

Undo

Venture Round in 2015
Undo Ltd. develops debugging tools for developers, software architects, product managers, and field application engineers. It offers live recorder that records and replay the execution of software, records the programming errors, debug the recordings, and integrates and automates container platform. The company also provides UndoDB, an interactive reversible debugger for C/C++ on Linux and Android. It serves data management, networking, electronic design automation, and financial industries. Undo Ltd. was incorporated in 2005 and is based in Cambridge, United Kingdom with an additional office location in San Francisco, California.
CMR Surgical is to make minimal access surgery available to all. With Versius they have delivered a next-generation tool to fit seamlessly into today’s operating rooms, working in harmony with the surgeon to improve patient outcomes and deliver value for healthcare providers.

Jukedeck

Venture Round in 2015
Jukedeck is developing an artificially intelligent music composer - a system that writes original music completely on its own. Jukedeck is based on state-of-the-art technology they are building that brings artificial intelligence to music composition and production. They are training deep neural networks to understand music composition at a granular level, so that they can build tools to aid creativity.

Riverlane

Series A in 2021
Riverlane is the most advanced quantum computing software developer
CMR Surgical is to make minimal access surgery available to all. With Versius they have delivered a next-generation tool to fit seamlessly into today’s operating rooms, working in harmony with the surgeon to improve patient outcomes and deliver value for healthcare providers.

PetMedix

Series B in 2021
PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. they are using the highest quality science to make the therapies their pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, they are applying the cutting edge of science to bring breakthroughs for the animals they love and care for.

AudioTelligence

Seed Round in 2018
AudioTelligence Ltd develops a software that pre-processes the sound and solves loud background noise problem that makes it difficult to hear or understand a conversation for humans and voice activated devices. The company delivers real-time audio processing technology for the enhancement of automatic speech recognition (ASR) systems. The company's software transforms the clarity and intelligibility of the audio. The company was founded in 2017 and is based in Cambridge, United Kingdom.

Abcodia Ltd.

Series B in 2015
Abcodia Ltd. engages in the discovery and validation of molecular biomarkers for disease diagnosis and screening. It offers Roca Test solutions for early ovarian cancer detection to customers in Arizona, Illinois, Massachusetts, New Jersey, Texas, Georgia, Michigan, Missouri, North Carolina, Nevada, Ohio, Oregon, Virginia, Washington, Wisconsin, the District of Columbia, and the United Kingdom. The company was incorporated in 2010 and is based in London, United Kingdom.

Gyroscope Therapeutics

Series C in 2021
Gyroscope is an ophthalmology company developing gene therapies for the treatment of eye diseases linked to an unbalanced complement system. Gyroscope was founded to explore the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD) and gene therapy as a mode of treatment delivery.

Undo

Seed Round in 2015
Undo Ltd. develops debugging tools for developers, software architects, product managers, and field application engineers. It offers live recorder that records and replay the execution of software, records the programming errors, debug the recordings, and integrates and automates container platform. The company also provides UndoDB, an interactive reversible debugger for C/C++ on Linux and Android. It serves data management, networking, electronic design automation, and financial industries. Undo Ltd. was incorporated in 2005 and is based in Cambridge, United Kingdom with an additional office location in San Francisco, California.

Microbiotica Limited

Series B in 2022
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and in vivo models.

Origami Energy Ltd.

Series A in 2016
Origami Energy Ltd., a technology company, develops and commercializes a technology platform for distributed energy applications. It offers technology and solutions to connect, control, and manage a network of existing energy generating/energy using/energy storing assets connected to the electricity grid. The company was incorporated in 2013 and is based in London, United Kingdom.

Gyroscope Therapeutics

Series B in 2019
Gyroscope is an ophthalmology company developing gene therapies for the treatment of eye diseases linked to an unbalanced complement system. Gyroscope was founded to explore the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD) and gene therapy as a mode of treatment delivery.

Cytora

Series A in 2017
Cytora transforms underwriting for commercial insurance. The Cytora Risk Engine uses artificial intelligence to learn the patterns of risks over time, enabling insurers to underwrite more efficiently and deliver fairer prices to customers. The company's goal is to raise the insurance industry to a new standard where insurance is fast and built on a foundation of tractable data. The company's products allow insurers to enhance underwriting profitability. Cytora was founded on 2014 and is headquartered in London.

Origami Energy Ltd.

Series C in 2021
Origami Energy Ltd., a technology company, develops and commercializes a technology platform for distributed energy applications. It offers technology and solutions to connect, control, and manage a network of existing energy generating/energy using/energy storing assets connected to the electricity grid. The company was incorporated in 2013 and is based in London, United Kingdom.
Sense Biodetection Limited provides molecular diagnostics solutions. The company offers True Point-of-Care, a clinical diagnostic product for users that would improve treatment and enable informed decisions in a decentralized healthcare system. The company was incorporated in 2013 and is headquartered in Abingdon, United Kingdom.

Bicycle Therapeutics

Series B in 2018
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Morphogen-IX Limited

Series A in 2016
Morphogen-IX Limited operates as a biotechnology company developing treatment for pulmonary arterial hypertension (PAH). The company was incorporated in 2015 and is headquartered in Cambridge, United Kingdom.

Seldon

Series A in 2020
Seldon Technologies Ltd. operates an open-source machine learning deployment platform. Its Seldon Deploy, which enables data science specialists to move into production more easily with compliance, also offers audit trails and approvals along with detailed explanations. The company was founded in 2014 and is based in Shoreditch, United Kingdom.

Z Factor

Series A in 2017
Z Factor Limited is a drug discovery company founded in 2015 to identify and develop therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was created by Index Ventures in partnership with the University of Cambridge.

Audio Analytic Ltd.

Series B in 2019
Audio Analytic is the pioneer of sound recognition and is on a mission to give all machines a sense of hearing beyond speech and music. Its embedded, cloudless AI software gives consumer technology the sense of hearing. By understanding what is happening around these products Audio Analytic provides devices and services with contextual awareness, that empower multiple applications across key values such as safety, security, wellbeing, health, entertainment, and communication. Founded in 2010, Audio Analytic is based in Cambridge, UK.
CMR Surgical is to make minimal access surgery available to all. With Versius they have delivered a next-generation tool to fit seamlessly into today’s operating rooms, working in harmony with the surgeon to improve patient outcomes and deliver value for healthcare providers.

Imagen Ltd

Series B in 2019
Imagen Ltd designs and develops media archive management solutions. The company offers Imagen2, a media asset management and publishing system; ImagenCloud, a cloud based system to manage and publish videos and images; and Orbital, a compliance recording system. Its clientele include Ministry of Defence, The Police, The BBC, ITN, The Imperial War Museum, British Telecom, and British Pathe. Imagen Ltd was formerly known as Cambridge Imaging Systems Limited and changed its name to Imagen Ltd in August 2015. The company was founded in 1991 and is based in Willingham, United Kingdom.

Jukedeck

Seed Round in 2014
Jukedeck is developing an artificially intelligent music composer - a system that writes original music completely on its own. Jukedeck is based on state-of-the-art technology they are building that brings artificial intelligence to music composition and production. They are training deep neural networks to understand music composition at a granular level, so that they can build tools to aid creativity.

Undo

Series A in 2016
Undo Ltd. develops debugging tools for developers, software architects, product managers, and field application engineers. It offers live recorder that records and replay the execution of software, records the programming errors, debug the recordings, and integrates and automates container platform. The company also provides UndoDB, an interactive reversible debugger for C/C++ on Linux and Android. It serves data management, networking, electronic design automation, and financial industries. Undo Ltd. was incorporated in 2005 and is based in Cambridge, United Kingdom with an additional office location in San Francisco, California.

GeoSpock Ltd.

Series A in 2015
GeoSpock Limited develops data indexing platform, which provides analytics, builds insight, and enables predictions across space and time. The company's products include GeoSpock DB Discovery and GeoSpock DB Enterprise that offers cloud-based database service for all location tagged information and enables the user to carry out dynamic data fusion and query complex data for performance analytics. It powers any location based service from real time tracking of entire logistics fleets to local taxi finding application. The company was incorporated in 2013 and is based in Cambridge, United Kingdom with additional offices in Tokyo, Japan; and Singapore.

PROWLER.IO

Series A in 2017
Founded in 2016 with a mission to empower people in business to make better decisions, Secondmind - The Decisions Company - is underpinned by years of award-winning, practical artificial intelligence (AI) and machine learning (ML) research, performed by a team of world-class researchers, data scientists and ML engineers. Secondmind closes the gap between people and AI, and supercharges decision-making with the Secondmind Decision Engine, an intuitive and insightful software platform that helps people in industries from supply chain to automotive predict, plan, influence outcomes, manage risk, and make complex decisions with ease and confidence. Secondmind is backed by leading venture funds including Amadeus Capital, Atlantic Bridge, and Cambridge Innovation Capital, among others.

Imagen Ltd

Venture Round in 2016
Imagen Ltd designs and develops media archive management solutions. The company offers Imagen2, a media asset management and publishing system; ImagenCloud, a cloud based system to manage and publish videos and images; and Orbital, a compliance recording system. Its clientele include Ministry of Defence, The Police, The BBC, ITN, The Imperial War Museum, British Telecom, and British Pathe. Imagen Ltd was formerly known as Cambridge Imaging Systems Limited and changed its name to Imagen Ltd in August 2015. The company was founded in 1991 and is based in Willingham, United Kingdom.

Storm Therapeutics Limited

Seed Round in 2015
Storm Therapeutics Limited discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. Storm Therapeutics Limited was formerly known as Iceni Therapeutics Limited and changed its name to Storm Therapeutics Limited in June 2016. The company was incorporated in 2015 and is based in Cambridge, United Kingdom.

PragmatIC Printing

Venture Round in 2016
PragmatIC Printing Limited, trading as PragmatIC, designs and manufactures flexible integrated circuits. The company offers flexible integrated circuit building blocks supporting different functions; a process design kit for integration with an existing electronic design automation environment; proximity field communication products for capacitive energy transfer; near field communications solutions; solutions for driving displays or visual indicators; and solutions support analogue interfaces to sense environmental inputs. Its products are used in smart packaging, security features, toys and games, hybrid electronics, and other applications. The company serves customers across consumer goods, packaging, security printing, and mainstream electronics sectors. PragmatIC Printing Limited was formerly known as Nano ePrint Ltd. and changed its name to PragmatIC Printing Limited in December 2011. The company was founded in 2006 and is based in Cambridge, United Kingdom with an additional production facility in Sedgefield, United Kingdom.

Swim.ai

Series B in 2018
Swim.Ai, Inc. develops advance analytics software that processes data in devices at the edge of a network. The company’s product includes SWIM EDX turns all streaming edge data into insights and predictions in real-time without the challenges of big data. It offers solutions for original equipment manufacturers, service providers, enterprises, cities, Internet of Things (IoT) vendors, and developers. It combines edge computing, machine learning, and self-training digital twins in mesh architecture. The company was founded in 2015 and is based in San Jose, California.

PredictImmune Ltd

Series B in 2019
PredictImmune is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis). Based on world-leading research at Cambridge University, UK, they are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payors all recognise the value of such an approach to the management of Inflammatory Bowel Disease.

PragmatIC Printing

Venture Round in 2019
PragmatIC Printing Limited, trading as PragmatIC, designs and manufactures flexible integrated circuits. The company offers flexible integrated circuit building blocks supporting different functions; a process design kit for integration with an existing electronic design automation environment; proximity field communication products for capacitive energy transfer; near field communications solutions; solutions for driving displays or visual indicators; and solutions support analogue interfaces to sense environmental inputs. Its products are used in smart packaging, security features, toys and games, hybrid electronics, and other applications. The company serves customers across consumer goods, packaging, security printing, and mainstream electronics sectors. PragmatIC Printing Limited was formerly known as Nano ePrint Ltd. and changed its name to PragmatIC Printing Limited in December 2011. The company was founded in 2006 and is based in Cambridge, United Kingdom with an additional production facility in Sedgefield, United Kingdom.

Congenica Ltd.

Series A in 2015
Congenica Ltd. develops and operates clinical data solutions for genetic diagnosis worldwide. The company offers Sapientia, a clinical genomic analytics platform that provides integration of human DNA sequences with deep clinical phenotyping, enabling clinicians and researchers to provide actionable interpretation of genetic disease for patients. Its platform is also used for clinical diagnosis, prognosis, and research by clinicians and researchers. The company’s platform is also used in personalized medicine applications, such as creating disease registries, identifying patient populations for clinical studies, and discovering novel drug targets and biomarkers. Congenica Ltd. was incorporated in 2012 and is based in Hinxton, United Kingdom.
Storm Therapeutics Limited discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. Storm Therapeutics Limited was formerly known as Iceni Therapeutics Limited and changed its name to Storm Therapeutics Limited in June 2016. The company was incorporated in 2015 and is based in Cambridge, United Kingdom.

Morphogen-IX Limited

Series B in 2018
Morphogen-IX Limited operates as a biotechnology company developing treatment for pulmonary arterial hypertension (PAH). The company was incorporated in 2015 and is headquartered in Cambridge, United Kingdom.

PolyProx Therapeutics Ltd

Seed Round in 2019
PolyProx Therapeutics is developer of a novel class of drug intended to provide new therapies for cancer treatment. The company's drug will use novel engineered protein that is able to selectively target tumour cells and trigger natural degradation machinery within the cell, enabling cancer patients to benefit from the treatment that targets and remove disease-causing proteins.

PROWLER.IO

Series B in 2019
Founded in 2016 with a mission to empower people in business to make better decisions, Secondmind - The Decisions Company - is underpinned by years of award-winning, practical artificial intelligence (AI) and machine learning (ML) research, performed by a team of world-class researchers, data scientists and ML engineers. Secondmind closes the gap between people and AI, and supercharges decision-making with the Secondmind Decision Engine, an intuitive and insightful software platform that helps people in industries from supply chain to automotive predict, plan, influence outcomes, manage risk, and make complex decisions with ease and confidence. Secondmind is backed by leading venture funds including Amadeus Capital, Atlantic Bridge, and Cambridge Innovation Capital, among others.
CMR Surgical is to make minimal access surgery available to all. With Versius they have delivered a next-generation tool to fit seamlessly into today’s operating rooms, working in harmony with the surgeon to improve patient outcomes and deliver value for healthcare providers.
Sense Biodetection Limited provides molecular diagnostics solutions. The company offers True Point-of-Care, a clinical diagnostic product for users that would improve treatment and enable informed decisions in a decentralized healthcare system. The company was incorporated in 2013 and is headquartered in Abingdon, United Kingdom.

Cytora

Series B in 2019
Cytora transforms underwriting for commercial insurance. The Cytora Risk Engine uses artificial intelligence to learn the patterns of risks over time, enabling insurers to underwrite more efficiently and deliver fairer prices to customers. The company's goal is to raise the insurance industry to a new standard where insurance is fast and built on a foundation of tractable data. The company's products allow insurers to enhance underwriting profitability. Cytora was founded on 2014 and is headquartered in London.

GeoSpock Ltd.

Series A in 2018
GeoSpock Limited develops data indexing platform, which provides analytics, builds insight, and enables predictions across space and time. The company's products include GeoSpock DB Discovery and GeoSpock DB Enterprise that offers cloud-based database service for all location tagged information and enables the user to carry out dynamic data fusion and query complex data for performance analytics. It powers any location based service from real time tracking of entire logistics fleets to local taxi finding application. The company was incorporated in 2013 and is based in Cambridge, United Kingdom with additional offices in Tokyo, Japan; and Singapore.

Microbiotica Limited

Seed Round in 2016
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and in vivo models.

AudioTelligence

Series A in 2020
AudioTelligence Ltd develops a software that pre-processes the sound and solves loud background noise problem that makes it difficult to hear or understand a conversation for humans and voice activated devices. The company delivers real-time audio processing technology for the enhancement of automatic speech recognition (ASR) systems. The company's software transforms the clarity and intelligibility of the audio. The company was founded in 2017 and is based in Cambridge, United Kingdom.

Congenica Ltd.

Series C in 2020
Congenica Ltd. develops and operates clinical data solutions for genetic diagnosis worldwide. The company offers Sapientia, a clinical genomic analytics platform that provides integration of human DNA sequences with deep clinical phenotyping, enabling clinicians and researchers to provide actionable interpretation of genetic disease for patients. Its platform is also used for clinical diagnosis, prognosis, and research by clinicians and researchers. The company’s platform is also used in personalized medicine applications, such as creating disease registries, identifying patient populations for clinical studies, and discovering novel drug targets and biomarkers. Congenica Ltd. was incorporated in 2012 and is based in Hinxton, United Kingdom.

Riverlane

Seed Round in 2019
Riverlane is the most advanced quantum computing software developer

PervasID

Series A in 2016
PervasID is developing a high reliability, wide area passive RFID system with the potential to provide location capability based on the EPC Class1 Gen2 standard. Spun out from research activity in the Engineering Department at the University of Cambridge, the technology is now successfully deployed in several field trials.

Congenica Ltd.

Series B in 2017
Congenica Ltd. develops and operates clinical data solutions for genetic diagnosis worldwide. The company offers Sapientia, a clinical genomic analytics platform that provides integration of human DNA sequences with deep clinical phenotyping, enabling clinicians and researchers to provide actionable interpretation of genetic disease for patients. Its platform is also used for clinical diagnosis, prognosis, and research by clinicians and researchers. The company’s platform is also used in personalized medicine applications, such as creating disease registries, identifying patient populations for clinical studies, and discovering novel drug targets and biomarkers. Congenica Ltd. was incorporated in 2012 and is based in Hinxton, United Kingdom.

Fluidic Analytics Limited

Series B in 2016
Fluidic Analytics Limited designs, develops, and manufactures equipment for the characterization of proteins in laboratory, medical, and consumer applications. The company provides Fluidity One, a product that enables in-solution sizing and quantification of native protein. The company also offers Fluidity One-W, a product that enables high sensitivity in-solution analysis of protein size and protein interaction kinetics. Its products are used for applications, including protein quality, interactions, aggregation, and sizing. The company serves scientists, clinics, and healthcare providers. Fluidic Analytics Limited was founded in 2013 and is based in Cambridge, United Kingdom.

CEDAR Audio

Seed Round in 2018
CEDAR Audio is the world's only company dedicated solely to audio restoration and speech enhancement for film, post, TV and radio broadcast, CD and DVD mastering, libraries and archives, and for audio forensic investigation. Established in 1988 following five years of research funded by the British Library National Sound Archive, CEDAR Audio is based in Cambridge, UK, and retains strong academic links with Cambridge University, itself one of the world's leading centres for digital signal processing research. The company currently numbers two Cambridge University Professors and a Director of Studies among its Directors, further strengthening its ability to remain at the forefront of its field. CEDAR Audio is committed to furthering the science and technology of audio restoration and speech enhancements in all its forms. It not only manufactures many of the leading products in these fields, but actively pursues research into new techniques in each of them. The company also places a premium on the highest standards of customer support, and has earned numerous accolades in this area.

PragmatIC Printing

Venture Round in 2015
PragmatIC Printing Limited, trading as PragmatIC, designs and manufactures flexible integrated circuits. The company offers flexible integrated circuit building blocks supporting different functions; a process design kit for integration with an existing electronic design automation environment; proximity field communication products for capacitive energy transfer; near field communications solutions; solutions for driving displays or visual indicators; and solutions support analogue interfaces to sense environmental inputs. Its products are used in smart packaging, security features, toys and games, hybrid electronics, and other applications. The company serves customers across consumer goods, packaging, security printing, and mainstream electronics sectors. PragmatIC Printing Limited was formerly known as Nano ePrint Ltd. and changed its name to PragmatIC Printing Limited in December 2011. The company was founded in 2006 and is based in Cambridge, United Kingdom with an additional production facility in Sedgefield, United Kingdom.

Bicycle Therapeutics

Series B in 2018
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Audio Analytic Ltd.

Venture Round in 2016
Audio Analytic is the pioneer of sound recognition and is on a mission to give all machines a sense of hearing beyond speech and music. Its embedded, cloudless AI software gives consumer technology the sense of hearing. By understanding what is happening around these products Audio Analytic provides devices and services with contextual awareness, that empower multiple applications across key values such as safety, security, wellbeing, health, entertainment, and communication. Founded in 2010, Audio Analytic is based in Cambridge, UK.